Ⓐ
PeptiBrief
Peptide medicine or biologic

Exendin 4

Exendin 4 has substantial clinical or physiological evidence, although approval, formulation and indication must be assessed specifically.

Evidence confidence

Human
Not yet assessed
Trust Engine review pending.
Animal
Not yet assessed
Trust Engine review pending.
Mechanistic
Not yet assessed
Trust Engine review pending — see editorial links below.
Editorial evidence links exist, but this category has not yet completed Trust Engine assessment.
Safety
Not yet assessed
Trust Engine review pending.

Claimed uses

Mechanisms

Safety notes

Adverse effects, contraindications and monitoring requirements depend on the approved or studied formulation.

Regulation
  • Approval and prescribing status vary by jurisdiction and indication.
Last reviewed
12 July 2026
Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.